Literature DB >> 3000653

The effects of ACTH on the renin-aldosterone system in normotensive man.

J A Whitworth, J Butty, D Saines, B Scoggins, R Thatcher.   

Abstract

The present study examined the effects of low dose ACTH administration (0.1 mg/day for 2 days) on plasma renin concentration, (PRC), activity (PRA) and substrate (PRS), cortisol and aldosterone in man. Six healthy male volunteers on a diet calculated to contain 150 mmol Na/day received an infusion of 5% dextrose (6 ml/h) for 24 hours, then ACTH (Synacthen, Ciba-Geigy) was added to the infusion at the rate of 100 micrograms per day, for 48 h. Blood samples were taken four hourly for determination of plasma cortisol, aldosterone, PRC, PRA and PRS. There was a highly significant increase in plasma cortisol and aldosterone concentrations during ACTH infusion compared with dextrose infusion, but no significant increase in active or inactive PRC, PRA or PRS. In a separate study of 15 healthy male volunteers, dexamethasone (1 mg at 2300 h) suppressed plasma cortisol but had no effect on PRC. These results do not support the view that stimulation of aldosterone by ACTH is mediated through the renin angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000653     DOI: 10.3109/10641968509073597

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  2 in total

1.  ACTH-induced hypertension is dependent on the ouabain-binding site of the alpha2-Na+-K+-ATPase subunit.

Authors:  John N Lorenz; Elizabeth L Loreaux; Iva Dostanic-Larson; Valerie Lasko; J Renee Schnetzer; Richard J Paul; Jerry B Lingrel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-16       Impact factor: 4.733

2.  The renin-angiotensin-aldosterone system in patients with depression compared to controls--a sleep endocrine study.

Authors:  Harald Murck; Katja Held; Marc Ziegenbein; Heike Künzel; Kathrin Koch; Axel Steiger
Journal:  BMC Psychiatry       Date:  2003-10-29       Impact factor: 3.630

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.